Literature DB >> 8119218

Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats.

S S Mirvish1, Q Huang, S C Chen, D F Birt, G W Clark, R A Hinder, T C Smyrk, T R DeMeester.   

Abstract

The mechanism is discussed by which certain nitrosamines induce esophageal papillomas and squamous cancer in rats, and some evidence is presented for the view that nitrosamines also induce the same cancer in humans, especially in China and South Africa. Studies on the metabolism of nitrosamines by cytochrome P450 isozymes in rat and human esophagus, including the activation reactions of formaldehyde and pentaldehyde formation from methyl-n-amylnitrosamine (MNAN), are reviewed. These reactions are catalyzed by microsomes from the rat and human esophagus, probably because these microsomes contain specific cytochrome P450 isozymes. Evidence is reviewed for the occurrence of nitrosamines related to MNAN in fungus-infected corn. The incidence of esophageal adenocarcinoma is rising in Western countries. The precursor lesion, Barrett's esophagus, is associated with colon cancer, suggesting a role for bile salts in the induction of the esophageal tumor. Studies are described in which rats were subjected to esophago-duodenostomy (joining the duodenum to the esophagus) and then treated with nitrosamines that normally induce esophageal squamous cancer. Adenocarcinomas of the lower esophagus were induced as well as Barrett's esophagus (under one set of conditions). Feeding a high-fat diet with this system increased the incidence of esophageal adenocarcinoma. This tumor was not induced when the operation was changed to esophago-gastroplasty (widening the lower esophageal sphincter). These results support a role of reflux of duodenal contents (including bile and pancreatic juice) rather than of gastric contents in the etiology of human esophageal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8119218     DOI: 10.1055/s-2007-1010418

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  Ileocecal valve as substitute for the missing pyloric sphincter after partial distal gastrectomy.

Authors:  Jürg Metzger; Lukas P Degen; Christoph Beglinger; Martin Siegemund; Wolfgang Studer; Michael Heberer; Felix Harder; Markus O von Flüe
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

2.  Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers.

Authors:  K Straif; S K Weiland; M Bungers; D Holthenrich; D Taeger; S Yi; U Keil
Journal:  Occup Environ Med       Date:  2000-03       Impact factor: 4.402

3.  Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected.

Authors:  C Yeh; C T Hsu; A S Ho; R E Sampliner; R Fass
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

4.  Validation of a rodent model of Barrett's esophagus using quantitative gene expression profiling.

Authors:  Daniel S Oh; Steven R DeMeester; Christy M Dunst; Ryutaro Mori; Bethany J Lehman; Hidekazu Kuramochi; Kathleen Danenberg; Peter Danenberg; Jeffrey A Hagen; Parakrama Chandrasoma; Tom R DeMeester
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

Review 5.  Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus.

Authors:  Joerg Theisen; Jeffrey H Peters; Hubert J Stein
Journal:  World J Surg       Date:  2003-07-17       Impact factor: 3.352

Review 6.  From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Rui-Hua Wang
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 7.  Drinking water and cancer.

Authors:  R D Morris
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

8.  Cytotoxicity of fumonisin B1, diethylnitrosamine, and catechol on the SNO esophageal cancer cell line.

Authors:  Rene B Myburg; Michael F Dutton; Anil A Chuturgoon
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.